查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1417249

干癣性关节炎治疗市场报告：2030 年趋势、预测与竞争分析

Psoriatic Arthritis Treatment Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 - page report | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

干癣性关节炎的治疗趋势和预测

至2030年，全球干癣性关节炎治疗市场预计将达到157.7亿美元，2024年至2030年的复合年增长率为9.6%。该市场的主要驱动因素是老年人口的增加和干癣性关节炎盛行率的上升，从而增加了对该产品的需求。干癣性关节炎治疗的研究和开发工作正在迅速增加，除了有关干癣性关节炎治疗的知识不断增加之外，我们还看到大量​​用于银屑病关节炎的新药、生物製药和生物仿製药。为此，研发活动激增。全球干癣性关节炎治疗市场的未来看起来充满希望，医院药房、零售药房和线上药房市场充满机会。

干癣性关节炎治疗市场的见解

Lucintel 预测，由于生物疗法在疾病管理方面的有效性，生物治疗的使用不断增加，因此缓解疾病的生物抗风湿药物将在预测期内实现最高增长。

由于干癣性关节炎的发生率和学名药数量的增加，预计亚太地区在预测期内将出现最高的增长。

常问问题

Q.1干癣性关节炎治疗的市场规模有多大：

A1. 到 2030 年，全球干癣性关节炎治疗市场预计将达到 157.7 亿美元。

Q.2干癣性关节炎治疗市场的成长预测是多少：

A2. 2024年至2030年，全球干癣性关节炎治疗市场预计将以9.6%的复合年增长率成长。

Q.3 影响干癣性关节炎治疗市场成长的关键因素有哪些：

A3. 此市场的主要驱动因素是老年人口的增加和干癣性关节炎盛行率的增加，以及对治疗干癣性关节炎的产品的需求增加。干癣性关节炎治疗的研究和开发工作正在迅速增加，除了有关干癣性关节炎治疗的知识不断增加之外，我们还看到大量​​用于银屑病关节炎的新药、生物製药和生物仿製药。为此，研发活动激增。

Q4.市场的主要细分市场是：

A4.干癣性关节炎治疗市场的前景看好，医院药局、零售药局和线上药局市场都有机会。

Q5.市场的主要企业是：

A5. 主要的干癣性关节炎治疗公司如下。

  • F. Hoffmann-La Roche
  • Novartis
  • Amgen
  • Pfizer
  • Johnson &Johnson Services
  • Eli Lilly and Company
  • AstraZeneca
  • Sanofi
  • Bristol-Myers Squibb Company
  • GlaxoSmithKline

Q6.未来最大的细分市场是什么？

A6.Lucintel 预测，由于生物疗法在疾病管理方面的有效性，生物治疗的使用越来越多，因此生物缓解疾病抗风湿药物将在预测期内实现最高增长。我是。

Q7. 未来五年预计哪些地区的市场成长最大？

A7.由于干癣性关节炎的发生率和学名药数量的增加，预计亚太地区在预测期内将出现最高的增长。

Q8. 可以客製化报告吗？

A8. 是的，Lucintel 提供 10% 的客製化服务，无需额外付费。

目录

第一章执行摘要

第二章全球干癣性关节炎治疗市场：市场动态

  • 简介、背景、分类
  • 供应链
  • 产业驱动因素与挑战

第三章 2018-2030年市场趋势及预测分析

  • 宏观经济趋势（2018-2023）与预测（2024-2030）
  • 全球干癣性关节炎治疗市场趋势（2018-2023）与预测（2024-2030）
  • 按药物类别分類的全球干癣性关节炎治疗市场
    • 非类固醇消炎剂
    • 非生物缓解疾病缓解抗风湿药物
    • 生物缓解疾病缓解抗风湿药物
    • 其他的
  • 按给药途径的全球干癣性关节炎治疗市场
    • 口服
    • 胃肠外的
    • 外用
  • 按分销管道分類的全球干癣性关节炎治疗市场
    • 医院药房
    • 零售药房
    • 网路药房

第四章 2018-2030年区域市场趋势及预测分析

  • 全球干癣性关节炎治疗市场（按地区）
  • 北美干癣性关节炎治疗市场
  • 欧洲干癣性关节炎治疗市场
  • 亚太地区干癣性关节炎治疗市场
  • 其他地区干癣性关节炎治疗市场

第五章 竞争分析

  • 产品系列分析
  • 营运整合
  • 波特五力分析

第六章 成长机会与策略分析

  • 成长机会分析
    • 按药物类别分類的全球干癣性关节炎治疗市场成长机会
    • 按给药途径的全球干癣性关节炎治疗市场成长机会
    • 全球干癣性关节炎治疗市场成长机会（按分销管道）
    • 全球干癣性关节炎治疗市场按地区成长机会
  • 全球干癣性关节炎治疗市场的新兴趋势
  • 战略分析
    • 新产品开发
    • 全球干癣性关节炎治疗市场的产能扩张
    • 全球干癣性关节炎治疗市场的合併、收购和合资企业
    • 认证和许可

第七章主要企业概况

  • F. Hoffmann-La Roche
  • Novartis
  • Amgen
  • Pfizer
  • Johnson & Johnson Services
  • Eli Lilly and Company
  • AstraZeneca
  • Sanofi
  • Bristol-Myers Squibb Company
  • GlaxoSmithKline
简介目录

Psoriatic Arthritis Treatment Trends and Forecast

The future of the global psoriatic arthritis treatment market looks promising with opportunities in the hospital pharmacies, retail pharmacies, and online pharmacies markets. The global psoriatic arthritis treatment market is expected to reach an estimated $15.77 billion by 2030 with a CAGR of 9.6% from 2024 to 2030. The major drivers for this market are rise in the senior population and psoriatic arthritis prevalence, increase in the demand for goods that treat psoriatic arthritis and a spike in research and development efforts to provide new medications for the condition, and robust pipeline of biologic and biosimilar drugs, as well as increased knowledge of psoriatic arthritis therapy.

A more than 150-page report is developed to help in your business decisions.

Psoriatic Arthritis Treatment by Segment

The study includes a forecast for the global psoriatic arthritis treatment by drugs class, route of administration , distribution channel, and region.

Psoriatic Arthritis Treatment Market by Drugs Class [Shipment Analysis by Value from 2018 to 2030]:

  • Non-steroidal Anti-inflammatory Drugs
  • Non-biologic Disease Modifying Anti-Rheumatic Drugs
  • Biologic Disease Modifying Anti-Rheumatic Drugs
  • Others

Psoriatic Arthritis Treatment Market by Route of Administration [Shipment Analysis by Value from 2018 to 2030]:

  • Oral
  • Parenteral
  • Topical

Psoriatic Arthritis Treatment Market by Distribution Channel [Shipment Analysis by Value from 2018 to 2030]:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Psoriatic Arthritis Treatment Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Psoriatic Arthritis Treatment Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies psoriatic arthritis treatment companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the psoriatic arthritis treatment companies profiled in this report include-

  • F. Hoffmann-La Roche
  • Novartis
  • Amgen
  • Pfizer
  • Johnson & Johnson Services
  • Eli Lilly And Company
  • Astrazeneca
  • Sanofi
  • Bristol-Myers Squibb Company
  • Glaxosmithkline

Psoriatic Arthritis Treatment Market Insights

Lucintel forecasts that biologic disease modifying anti-rheumatic drugs is expected to witness highest growth over the forecast period due to increasing use of biological treatments as a result of their effectiveness in managing the illness.

APAC is expected to witness highest growth over the forecast period due to rising rates of psoriatic arthritis instances and the quantity of generic medications.

Features of the Global Psoriatic Arthritis Treatment Market

Market Size Estimates: Psoriatic arthritis treatment market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Psoriatic arthritis treatment market size by drugs class, route of administration , distribution channel, and region in terms of value ($B).

Regional Analysis: Psoriatic arthritis treatment market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different drugs class, route of administration , distribution channel, and regions for the psoriatic arthritis treatment market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the psoriatic arthritis treatment market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the psoriatic arthritis treatment market size?

Answer: The global psoriatic arthritis treatment market is expected to reach an estimated $15.77 billion by 2030.

Q.2 What is the growth forecast for psoriatic arthritis treatment market?

Answer: The global psoriatic arthritis treatment market is expected to grow with a CAGR of 9.6% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the psoriatic arthritis treatment market?

Answer: The major drivers for this market are rise in the senior population and psoriatic arthritis prevalence, increase in the demand for goods that treat psoriatic arthritis and a spike in research and development efforts to provide new medications for the condition, and robust pipeline of biologic and biosimilar drugs, as well as increased knowledge of psoriatic arthritis therapy.

Q4. What are the major segments for psoriatic arthritis treatment market?

Answer: The future of the psoriatic arthritis treatment market looks promising with opportunities in the hospital pharmacies, retail pharmacies, and online pharmacies markets.

Q5. Who are the key psoriatic arthritis treatment market companies?

Answer: Some of the key psoriatic arthritis treatment companies are as follows.

  • F. Hoffmann-La Roche
  • Novartis
  • Amgen
  • Pfizer
  • Johnson & Johnson Services
  • Eli Lilly and Company
  • AstraZeneca
  • Sanofi
  • Bristol-Myers Squibb Company
  • GlaxoSmithKline

Q6. Which psoriatic arthritis treatment market segment will be the largest in future?

Answer: Lucintel forecasts that biologic disease modifying anti-rheumatic drugs is expected to witness highest growth over the forecast period due to increasing use of biological treatments as a result of their effectiveness in managing the illness.

Q7. In psoriatic arthritis treatment market, which region is expected to be the largest in next 5 years?

Answer: APAC is expected to witness highest growth over the forecast period due to rising rates of psoriatic arthritis instances and the quantity of generic medications.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the psoriatic arthritis treatment market by drugs class (non-steroidal anti-inflammatory drugs, non-biologic disease modifying anti-rheumatic drugs, biologic disease modifying anti-rheumatic drugs, and others), route of administration (oral, parenteral, and topical), distribution channel (hospital pharmacies, retail pharmacies, and online pharmacies), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Psoriatic Arthritis Treatment Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Psoriatic Arthritis Treatment Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Psoriatic Arthritis Treatment Market by Drugs Class
    • 3.3.1: Non-steroidal Anti-inflammatory Drugs
    • 3.3.2: Non-biologic Disease Modifying Anti-Rheumatic Drugs
    • 3.3.3: Biologic Disease Modifying Anti-Rheumatic Drugs
    • 3.3.4: Others
  • 3.4: Global Psoriatic Arthritis Treatment Market by Route of Administration
    • 3.4.1: Oral
    • 3.4.2: Parenteral
    • 3.4.3: Topical
  • 3.5: Global Psoriatic Arthritis Treatment Market by Distribution Channel
    • 3.5.1: Hospital Pharmacies
    • 3.5.2: Retail Pharmacies
    • 3.5.3: Online Pharmacies

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Psoriatic Arthritis Treatment Market by Region
  • 4.2: North American Psoriatic Arthritis Treatment Market
    • 4.2.2: North American Psoriatic Arthritis Treatment Market by Distribution Channel: Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies
  • 4.3: European Psoriatic Arthritis Treatment Market
    • 4.3.1: European Psoriatic Arthritis Treatment Market by Drugs Class: Non-steroidal Anti-inflammatory Drugs, Non-biologic Disease Modifying Anti-Rheumatic Drugs, Biologic Disease Modifying Anti-Rheumatic Drugs, and Others
    • 4.3.2: European Psoriatic Arthritis Treatment Market by Distribution Channel: Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies
  • 4.4: APAC Psoriatic Arthritis Treatment Market
    • 4.4.1: APAC Psoriatic Arthritis Treatment Market by Drugs Class: Non-steroidal Anti-inflammatory Drugs, Non-biologic Disease Modifying Anti-Rheumatic Drugs, Biologic Disease Modifying Anti-Rheumatic Drugs, and Others
    • 4.4.2: APAC Psoriatic Arthritis Treatment Market by Distribution Channel: Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies
  • 4.5: ROW Psoriatic Arthritis Treatment Market
    • 4.5.1: ROW Psoriatic Arthritis Treatment Market by Drugs Class: Non-steroidal Anti-inflammatory Drugs, Non-biologic Disease Modifying Anti-Rheumatic Drugs, Biologic Disease Modifying Anti-Rheumatic Drugs, and Others
    • 4.5.2: ROW Psoriatic Arthritis Treatment Market by Distribution Channel: Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Psoriatic Arthritis Treatment Market by Drugs Class
    • 6.1.2: Growth Opportunities for the Global Psoriatic Arthritis Treatment Market by Route of Administration
    • 6.1.3: Growth Opportunities for the Global Psoriatic Arthritis Treatment Market by Distribution Channel
    • 6.1.4: Growth Opportunities for the Global Psoriatic Arthritis Treatment Market by Region
  • 6.2: Emerging Trends in the Global Psoriatic Arthritis Treatment Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Psoriatic Arthritis Treatment Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Psoriatic Arthritis Treatment Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: F. Hoffmann-La Roche
  • 7.2: Novartis
  • 7.3: Amgen
  • 7.4: Pfizer
  • 7.5: Johnson & Johnson Services
  • 7.6: Eli Lilly and Company
  • 7.7: AstraZeneca
  • 7.8: Sanofi
  • 7.9: Bristol-Myers Squibb Company
  • 7.10: GlaxoSmithKline